SIMCERE PHARMACEUTICAL GROUP Financing Receivable, after Allowance for Credit Loss, Current
SIMCERE PHARMACEUTICAL GROUP had Financing Receivable, after Allowance for Credit Loss, Current of CNY 679.63 million as of 2012-12-31, per its 20-F filed 2013-04-26.
Discontinued › Balance Sheet › Assets › Assets, Current › Accounts and Financing Receivable, after Allowance for Credit Loss, Current › Financing Receivable, after Allowance for Credit Loss, Current
us-gaap:NotesAndLoansReceivableNetCurrent · last filed 2013-04-26
- 2012-12-31: Financing Receivable, after Allowance for Credit Loss, Current 679.63M CNY.
- 2011-12-31: Financing Receivable, after Allowance for Credit Loss, Current 814.82M CNY.
CNY
| Period end | Financing Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2012-12-31 | 679.63M CNY 20-F · filed 2013-04-26 |
| 2011-12-31 | 814.82M CNY 20-F · filed 2013-04-26 |
USD
| Period end | Financing Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2012-12-31 | $109.09M 20-F · filed 2013-04-26 |